Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis

Bias in meta-analysis detected by a simple, graphical test

Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works

Meta-analysis in clinical trials

DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · see citing works

The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants

Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,577 · see citing works

Assessing the quality of reports of randomized clinical trials: Is blinding necessary?

Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · see citing works

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609 · see citing works

Functional Bowel Disorders

Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856 · see citing works

Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis

Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,556 · see citing works

Bowel Disorders

Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866 · see citing works

Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155 · see citing works

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448 · see citing works

Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome

Rajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041 · see citing works

The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects

Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002 · see citing works

Risk and safety of probiotics

Doron, S., & Snydman, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ085 · Cited by 942 · see citing works

The epidemiology of irritable bowel syndrome

Card, T., Canavan, C., & West, J. (2014) · Clinical Epidemiology · doi:10.2147/clep.s40245 · Cited by 889 · see citing works

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota

Jeffery, I. B., O'Toole, P. W., Öhman, L., Claesson, M. J., Deane, J., Quigley, E. M. M., & Simrén, M. (2012) · Gut · doi:10.1136/gutjnl-2011-301501 · Cited by 835 · see citing works

Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome

Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'Mahony, L., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00734.x · Cited by 799 · see citing works

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome

Tap, J., Derrien, M., Törnblom, H., Brazeilles, R., Cools-Portier, S., Doré, J., Störsrud, S., Le Nevé, B., Öhman, L., & Simrén, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.049 · Cited by 642 · see citing works

Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome

Ford, A. C., Harris, L. A., Lacy, B. E., Quigley, E. M. M., & Moayyedi, P. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15001 · Cited by 619 · see citing works

Pathophysiology of irritable bowel syndrome

Holtmann, G. J., Ford, A. C., & Talley, N. J. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30023-1 · Cited by 590 · see citing works

Effect of Probiotics on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials

Khalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516 · see citing works

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome

Kim, H. J., Camilleri, M., Mckinzie, S., Lempke, M. B., Burton, D. D., Thomforde, G. M., & Zinsmeister, A. R. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01543.x · Cited by 468 · see citing works

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome

Carroll, I. M., Ringel‐Kulka, T., Siddle, J. P., & Ringel, Y. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01891.x · Cited by 425 · see citing works

Effect of a fermented milk containing <i>Bifidobacterium animalis</i> DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial

GUYONNET, D., CHASSANY, O., DUCROTTE, P., PICARD, C., MOURET, M., MERCIER, C. ‐., & MATUCHANSKY, C. (2007) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/j.1365-2036.2007.03362.x · Cited by 365 · see citing works

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6‐month intervention

KAJANDER, K., HATAKKA, K., POUSSA, T., FÄRKKILÄ, M., & KORPELA, R. (2005) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/j.1365-2036.2005.02579.x · Cited by 361 · see citing works

Faecal microbiota composition and host–microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome

Jalanka-Tuovinen, J., Salojärvi, J., Salonen, A., Immonen, O., Garsed, K., Kelly, F. M., Zaitoun, A., Palva, A., Spiller, R. C., & de Vos, W. M. (2014) · Gut · doi:10.1136/gutjnl-2013-305994 · Cited by 340 · see citing works

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double-blind, placebo-controlled study: Randomised clinical trial: B. bifidum MIMBb75 in IBS

Guglielmetti, S., Mora, D., Gschwender, M., & Popp, K. (2011) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/j.1365-2036.2011.04633.x · Cited by 287 · see citing works

Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome

Ducrotte, P. R. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i30.4012 · Cited by 273 · see citing works

Review article: probiotics for the treatment of irritable bowel syndrome – focus on lactic acid bacteria

Clarke, G. A., Cryan, J. F., Dinan, T. G., & Quigley, E. M. M. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04965.x · Cited by 217 · see citing works

Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome

Quartero, A. O., Meiniche-Schmidt, V., Muris, J., Rubin, G., & de Wit, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub2 · Cited by 190 · see citing works

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome

ZENG, J., LI, Y. ‐., ZUO, X. ‐., ZHEN, Y. ‐., YANG, J., & LIU, C. ‐. (2008) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/j.1365-2036.2008.03818.x · Cited by 189 · see citing works

Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome – a randomized, double-blind, controlled study

SIMRÉN, M., ÖHMAN, L., OLSSON, J., SVENSSON, U., OHLSON, K., POSSERUD, I., & STRID, H. (2010) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/j.1365-2036.2009.04183.x · Cited by 169 · see citing works

Epidemiology of Irritable Bowel Syndrome

Choung, R. S., & Saito, Y. A. (2014) · Wiley eBooks · doi:10.1002/9781118727072.ch20 · Cited by 163 · see citing works

Therapeutic Effect of Lactobacillus acidophilus-SDC 2012, 2013 in Patients with Irritable Bowel Syndrome

Sinn, D. H., Song, J. H., Kim, H. J., Lee, J. H., Son, H. J., Chang, D. K., Kim, Y.-H., Kim, J. J., Rhee, J. C., & Rhee, P.-L. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0196-4 · Cited by 163 · see citing works

Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study

WILLIAMS, E. A., STIMPSON, J., WANG, D., PLUMMER, S., GARAIOVA, I., BARKER, M. E., & CORFE, B. M. (2009) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/j.1365-2036.2008.03848.x · Cited by 156 · see citing works

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome

Drouault-Holowacz, S., Bieuvelet, S., Burckel, A., Cazaubiel, M., Dray, X., & Marteau, P. (2008) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2007.06.001 · Cited by 151 · see citing works

Randomised clinical trial: a liquid multi‐strain probiotic vs. placebo in the irritable bowel syndrome – a 12 week double‐blind study

Sisson, G., Ayis, S., Sherwood, R. A., & Bjarnason, I. (2014) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/apt.12787 · Cited by 147 · cited 2× · see citing works

A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome

Kruis, W., Chrubasik, S., Boehm, S., Stange, C., & Schulze, J. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1363-9 · Cited by 126 · see citing works

World Gastroenterology Organisation Global Guidelines Irritable Bowel Syndrome

Quigley, E. M. M., Fried, M., Gwee, K., Халиф, И. Л., Hungin, A. P. S., Lindberg, G., Abbas, Z., Fernández, L. B., Bhatia, S. J., Schmulson, M., et al. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000653 · Cited by 124 · see citing works

A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome

de Chambrun, G. P., Neut, C., Chau, A., Cazaubiel, M., Pélerin, F., Jüsten, P., & Desreumaux, P. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.11.007 · Cited by 119 · see citing works

A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome

Ishaque, S. M., Khosruzzaman, S. M., Ahmed, D. S., & Sah, M. P. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0788-9 · Cited by 109 · see citing works

Melatonin Regulation as a Possible Mechanism for Probiotic (VSL#3) in Irritable Bowel Syndrome: A Randomized Double-Blinded Placebo Study

Wong, R. K. M., Cao, Y., Song, G., Wong, J. Y. Y., & Ho, K. Y. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3299-8 · Cited by 107 · see citing works

Irritable bowel syndrome symptom severity improves equally with probiotic and placebo

Lyra, A., Hillilä, M., Huttunen, T., Männikkö, S., Taalikka, M., Tennilä, J., Tarpila, A., Lahtinen, S., Ouwehand, A. C., & Veijola, L. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10631 · Cited by 106 · see citing works

Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo

Enck, P., Zimmermann, K., Menke, G., & Klosterhalfen, S. (2009) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2008-1027702 · Cited by 100 · cited 2× · see citing works

A randomised controlled trial of a probiotic ‘functional food’ in the management of irritable bowel syndrome

Roberts, L. M., McCahon, D., HOLDER, R. L., Wilson, S., & Hobbs, R. F. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-45 · Cited by 87 · see citing works

Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome

Durbán, A., Abellán, J. J., Jiménez-Hernández, N., Artacho, A., Garrigues, V., Ortiz, V., Ponce, J., Latorre, A., & Moya, A. (2013) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12184 · Cited by 83 · see citing works

Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial

Begtrup, L. M., de Muckadell, O. B. S., Kjeldsen, J., Christensen, R. D., & Jarbøl, D. E. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.825314 · Cited by 82 · see citing works

A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation

Mezzasalma, V., Manfrini, E., Ferri, E., Sandionigi, A., La Ferla, B., Schiano, I., Michelotti, A., Nobile, V., Labra, M., & Di Gennaro, P. (2016) · BioMed Research International · doi:10.1155/2016/4740907 · Cited by 81 · see citing works

Effect of probiotics on symptoms in Korean adults with irritable bowel syndrome

Hong, K. S., Kang, H. W., Im, J. P., Ji, G. E., Kim, S. G., Jung, H. C., Song, I. S., & Kim, J. S. (2009) · Gut and Liver · doi:10.5009/gnl.2009.3.2.101 · Cited by 75 · see citing works

Effectiveness of Probiotics in the Prophylaxis of Necrotizing Enterocolitis in Preterm Neonates: A Systematic Review and Meta-analysis

Bernardo, W. M., Aires, F. T., Carneiro, R. M., de Sá, F. P., Rullo, V. E. V., & Burns, D. A. (2013) · Jornal de Pediatria · doi:10.1016/j.jped.2013.02.004 · Cited by 71 · see citing works

A double‐blind, placebo‐controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea‐predominant IBS

Hod, K., Sperber, A. D., Ron, Y., Boaz, M., Dickman, R. M., Berliner, S. A., Halpern, Z., Maharshak, N., & Dekel, R. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13037 · Cited by 70 · see citing works

Microbial signatures in post-infectious irritable bowel syndrome--toward patient stratification for improved diagnostics and treatment

Jalanka, J., Salonen, A., Fuentes, S., & de Vos, W. M. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1096486 · Cited by 61 · see citing works

Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: A randomized, placebo-controlled, double-blind study

Jones, M. L., Martoni, C., Tamber, S., Parent, M., & Prakash, S. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.03.010 · Cited by 49 · see citing works

Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients

Ludidi, S., Jonkers, D. M. A. E., Koning, C. J., Kruimel, J. W., Mulder, L. H. C., der Vaart, I. B.-V., Conchillo, J. M., & Masclee, A. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12320 · Cited by 49 · see citing works

Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating.

Jafari, E., Vahedi, H., Merat, S., Momtahen, S., & Riahi, A. (2014) · PubMed · Cited by 47 · see citing works

A double blind, placebo-controlled, randomized clinical trial that breast milk derived-&lt;i&gt;Lactobacillus gasseri&lt;/i&gt; BNR17 mitigated diarrhea-dominant irritable bowel syndrome

Shin, S. P., Choi, Y. M., Kim, W. H., Hong, S. P., Park, J.-M., Kim, J., Kwon, O., Lee, E. H., & Hahm, K. B. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-73 · Cited by 46 · see citing works

Multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.

Cui, S., & Hu, Y. (2012) · PubMed · Cited by 45 · see citing works

Quality of Life and Illness Costs in Irritable Bowel Syndrome

Simrén, M., Brazier, J. E., Coremans, G., Dapoigny, M. C., Müller-Lissner, S. A., Pace, F., Smout, A. J. P. M., Stockbrügger, R. W., Vatn, M. H., & Whorwell, P. J. (2004) · Digestion · doi:10.1159/000079846 · Cited by 39 · see citing works

2008 Clinical approach to irritable bowel syndrome.

Astegiano, M., Pellicano, R., Sguazzini, C., Berrutti, M., Simondi, D., Reggiani, S., & Rizzetto, M. (2008) · PubMed · Cited by 16 · see citing works

Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis

Person, H., & Keefer, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110209 · Cited by 158 · see citing works

Probiotic Supplements on Oncology Patients’ Treatment-Related Side Effects: A Systematic Review of Randomized Controlled Trials

Rodríguez-Arrastia, M. J., Martinez‐Ortigosa, A., Rueda‐Ruzafa, L., Ayora, A. F., & Ropero‐Padilla, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084265 · Cited by 93 · see citing works

Lactobacillus plantarum CCFM1143 Alleviates Chronic Diarrhea via Inflammation Regulation and Gut Microbiota Modulation: A Double-Blind, Randomized, Placebo-Controlled Study

Yang, B. K., Yue, Y., Chen, Y., Ding, M., Li, B., Wang, L., Wang, Q., Stanton, C., Ross, R. P., Zhao, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746585 · Cited by 69 · see citing works

Gastrointestinal symptoms, gut microbiome, probiotics and prebiotics in anorexia nervosa: A review of mechanistic rationale and clinical evidence

Dhopatkar, N., Keeler, J. L., Mutwalli, H., Whelan, K., Treasure, J. L., & Himmerich, H. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105959 · Cited by 57 · see citing works

Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials

Shang, X., E, F.-F., Guo, K.-L., Li, Y.-F., Zhao, H.-L., Wang, Y., Chen, N., Nian, T., Yang, C.-Q., Yang, K.-H., et al. (2022) · Nutrients · doi:10.3390/nu14122482 · Cited by 41 · see citing works

Milk Kefir therapy reduces inflammation and alveolar bone loss on periodontitis in rats

Vieira, L. V., de Sousa, L. M., Maia, T. A. C., Gusmão, J. N. F. M., Góes, P., Pereira, K. M. A., Miyajima, F., & Gondim, D. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111677 · Cited by 34 · see citing works

The Gut Microbiome and Its Implication in the Mucosal Digestive Disorders

Bozomitu, L. I., Miron, I. C., Răileanu, A. A., Lupu, A., Păduraru, G., Marcu, F. M., Buga, A. M. L., Rusu, D. C., Dragan, F., & Lupu, V. V. (2022) · Biomedicines · doi:10.3390/biomedicines10123117 · Cited by 33 · see citing works

Probiotics Modulate Host Immune Response and Interact with the Gut Microbiota: Shaping Their Composition and Mediating Antibiotic Resistance

Mousa, W. K., Mousa, S., Ghemrawi, R., Obaid, D. E. E., Sarfraz, M., Chehadeh, F., & Husband, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813783 · Cited by 33 · see citing works

An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome

Mousavi, T., Nikfar, S., & Abdollahi, M. R. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1767067 · Cited by 32 · see citing works

Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria

Konstantis, G., Efstathiou, S., Pourzitaki, C., Kitsikidou, E., Germanidis, G. S., & Chourdakis, M. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.03.019 · Cited by 31 · see citing works

The Role of Prebiotics and Probiotics in Human Health: A Systematic Review with a Focus on Gut and Immune Health

Gill Jenkins, P. M. (2022) · Food & Nutrition Journal · doi:10.29011/2575-7091.100245 · Cited by 21 · see citing works

Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine

Gigola, G., Carriere, P., Díaz, M. B. N., Perdigón, G., Zwenger, A. O., & Gentili, C. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i10.1518 · Cited by 16 · see citing works

Probiotics and gastrointestinal disorders: an umbrella meta-analysis of therapeutic efficacy

Zeng, Q., Li, P., Wu, H., Zhuang, Y., Zhang, Y., Asemani, S., Jamilian, P., Jamali, M., & Yu, H. (2025) · European journal of medical research · doi:10.1186/s40001-025-02788-w · Cited by 15 · see citing works

Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical Trials

Zeraattalab-Motlagh, S., Ranjbar, M., Mohammadi, H., & Adibi, P. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae107 · Cited by 11 · see citing works

Probiotics: are they beneficial?

Fehily, S. R., Basnayake, C., Wright, E. K., Yao, C. K., Godsell, J. D., Gibson, P. R., & Kamm, M. A. (2024) · Internal Medicine Journal · doi:10.1111/imj.16388 · Cited by 12 · see citing works

Could the Microbiota Be a Predictive Factor for the Clinical Response to Probiotic Supplementation in IBS-D? A Cohort Study

Marchix, J., Quénéhervé, L., Bordron, P., Aubert, P., Durand, T., Oullier, T., Blondeau, C., Abdellah, S. A., Varannes, S. B. D., Chaffron, S., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11020277 · Cited by 9 · see citing works

Probiotics Combined With Trimebutine for the Treatment of Irritable Bowel Syndrome Patients: A Systematic Review and Meta‐Analysis

Yu, Q., Wang, D., Dong, P., & Zheng, L. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16858 · Cited by 8 · see citing works

Probiotics: current regulatory aspects of probiotics for use in different disease conditions

Pogačar, M. Š., Mičetić‐Turk, D., & Fijan, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823733-5.00021-0 · Cited by 8 · see citing works

Lactobacillus gasseri LA806 Supplementation in Patients with Irritable Bowel Syndrome: A Multicenter Study

Abdellah, S. A., Scanzi, J., Gal, C., Martin, M., Beck, M., & Ojetti, V. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247446 · Cited by 7 · see citing works

Gut Microbiota Dysbiosis in Depression: Pathological Correlations, Molecular Pathways, and Therapeutic Interventions

Cao, J. J., Ma, J., Zha, X., Bian, X., Wang, W., & Liu, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031530 · Cited by 7 · see citing works

Determination of Probiotics Prescription Indications in Patients with Irritable Bowel Syndrome (Materials of the Expert Council and Literature Review)

Ivashkin, V., Maev, I., Alekseeva, O. P., Alekseenko, S., Korochanskaya, N. V., Poluektova, E., Simanenkov, V., Trukhmanov, A. S., Khlynov, I., Tsukanov, V., et al. (2022) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2022-32-2-9-18 · Cited by 5 · see citing works

Differences in provider recommendations for Black/African American and White patients with irritable bowel syndrome

Boyd, T., Garcia‐Fischer, I., Silvernale, C. J., Anyane‐Yeboa, A., & Staller, K. D. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14742 · Cited by 6 · see citing works

Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome

Maslennikov, R. V., Gosteeva, E., Ananeva, V., Korshunova, L., Kravtsowa, A., Poluektova, E., Ulyanin, A. I., Sigidaev, A. S., Kikhasurova, P. M., & Ivashkin, V. T. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15031152 · Cited by 10 · see citing works

Immobilization of Lactobacillus plantarum NCIMB 8826 ameliorates Citrobacter rodentium induced lesions and enhances the gut inflammatory response in C57BL/6 weanling mice

Kyereh, E., Coulon, D. B., Langohr, I. M., Raggio, A. M., Keenan, M. J., & Sathivel, S. (2022) · Food Production Processing and Nutrition · doi:10.1186/s43014-022-00111-2 · Cited by 4 · see citing works

A meta-analysis of the relationship between semantic distance and creative thinking

Yadan, L. I., Ying, D. U., Cong, X. I. E., Chunyu, L. I. U., Yilong, Y. A. N. G., Yangping, L. I., & Qiu, J. (2022) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2023.00519 · Cited by 4 · see citing works

Primer consenso centroamericano y del Caribe del síndrome de intestino irritable

Galdámez, J., Aguilar-Paiz, L., Blanco, G. M., Monge, S. C., de Mezerville-Cantillo, L., Castillo, P. N., Quintero, I., Polanco, E. D. P. R., Hernández, M. A. S., Sandoval, E., et al. (2023) · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · doi:10.52787/agl.v53i2.272 · Cited by 4 · see citing works

Evaluation of efficacy and safety of Bacillus coagulans SNZ 1969 supplementation for irritable bowel syndrome: a randomized, double-blind, placebo-controlled study

Soman, R. J., Gorantla, S. C., & Swamy, M. V. (2022) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20222353 · Cited by 3 · see citing works

Probiotics: To Use or Not to Use? That Is the Question

Schmulson, M. J. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001299 · Cited by 2 · see citing works

Síndrome do Intestino Irritável: uma revisão de literatura

Weber, J. B., Weber, C. D. S. B., & Ferraz, A. R. (2022) · Revista Eletrônica Acervo Médico · doi:10.25248/reamed.e11009.2022 · Cited by 1 · see citing works

Probiotics in Irritable Bowel Syndrome: An Umbrella Review of 27 Systematic Reviews on Methodological Quality and Certainty of Evidence

Ballena-Caicedo, J., Zuzunaga-Montoya, F. E., Acosta-Porzoliz, R. P. E., García-Ahumada, F. S., Rivera-Lozada, O., Valladares-Garrido, M. J., & Vera-Ponce, V. J. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15051727 · Cited by 1 · see citing works

The role of probiotics in current algorithms for the treatment of irritable bowel syndrome: A review

Андреев, Д. Н., & Maev, I. V. (2023) · Consilium Medicum · doi:10.26442/20751753.2023.5.202131 · Cited by 1 · see citing works

Post-Covid-19 irritable bowel syndrome – importance of diet therapy and probiotic therapy

Grońska, D., & Drzewowska, K. (2022) · Medycyna Ogólna i Nauki o Zdrowiu · doi:10.26444/monz/155260 · Cited by 1 · see citing works

Probióticos en dispepsia, microbiota y estreñimiento, gluten en el síndrome de intestino irritable y cannabinoides en trastornos motores y funcionales gastrointestinales

Schmulson, M. J., & Saps, M. (2021) · NeuroGastroLATAM Reviews · doi:10.24875/ngl.m20000018

Mechanism of Lactobacillus rhamnosus in treatment of irritable bowel syndrome

Su, S., Zhang, Z., Wang, X., Wang, Y., & Wang, B. (2021) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v29.i7.366

Letter to the editor regarding “The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients

Zhu, Q., & Tan, D. (2021) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_601_21

Adjuvant nutraceuticals in the management of gastrointestinal diseases

Balio, B. G., Giro, R., & Roriz, M. (2023) · Acta Portuguesa de Nutrição · doi:10.21011/apn.2023.3210

Modulation of microbiota as a target in the management of patients with irritable bowel syndrome

Livzan, M., & Gaus, O. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-366

Saccharomyces cerevisiae for abdominal pain and discomfort in irritable bowel syndrome patients

Siyal, M., Abbas, Z., Amir, M. R., & Qadeer, M. A. (2023) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.40.3.8349

Effect of Bacillus subtilis ATCC 122264 on intestinal gas symptoms and quality of life in adults with functional bloating

LeMoire, A., Lin, J., Girard, S., Baisley, J. E., Wang, J., Atif, A., Zahra, R., & Millette, M. (2025) · Beneficial Microbes · doi:10.1163/18762891-bja00057

The Combination of Anxiety and Depressive Disorders in Patients with Irritable Bowel Syndrome (Literature Review and Expert Council Resolution)

Ivashkin, V. T., Livzan, M. A., Abdulganieva, D., Alekseeva, O. P., Alekseenko, S. A., Бакулина, Н. В., Baranovsky, A. Y., Bordin, D. S., Volel, B. A., Zolnikova, O. Y., et al. (2026) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2026-36-2-7-24

The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials

Niu, H.-L., & Xiao, J. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.01.142 · Cited by 86 · see citing works

Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria

Konstantis, G., Efstathiou, S., Pourzitaki, C., Kitsikidou, E., Germanidis, G. S., & Chourdakis, M. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.03.019 · Cited by 31 · see citing works

Efficacy of probiotics in treatment of irritable bowel syndrome:a meta-analysis

Zhen-fe, Z. (2014) · Chinese Journal of New Drugs and Clinical Remedies

Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis

Didari, T. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i10.3072 · Cited by 356 · see citing works

The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review

Brenner, D. M., Moeller, M., Chey, W. D., & Schoenfeld, P. (2007) · The American Journal of Gastroenterology · doi:10.14309/00000434-200709002-01040 · Cited by 23 · see citing works